Biotech Movers: Optimer Rockets, Ziopharm in Free Fall

Shares of Optimer Pharmaceuticals rose on buyout speculation last week, while Ziopharm Oncology continued its plunge. More 

Dump These 5 First-Quarter Winners Now

Netflix, Hewlett-Packard, Avon, H&R Block and Best Buy all finished the first quarter with huge gains, but now is the time to get out of them before they crash More 

5 Stocks With Bad Operating Margin Growth — PGNX SYUT CTEL HKTV IMMU

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader. More 

Facebook Home: The Next Google Nexus, or MySpace Mobile Part II?

Facebook Home must convince users to further immerse themselves in the social media platform at a time where many are starting to migrate away. More 

Q1 Earnings: They’ll Suck. Sound Familiar?

S&P 500 firms are expected to post another YOY drop in profits. Hopefully, Wall Street looks at the prettier picture ahead. More 

Trouble Brewing in the Markets

Bearish price action is confirming the weak market internals, but the S&P 500 would need to fall through this level to really get me worried. More 

Book Publishing Giants Get OK to Merge

The merger between Bertelsmann's Random House and Pearson's Penguin has received approval from the European Commission. More